Department of Cardiology, Second Affiliated Hospital of Zhejiang University School of Medicine, Key Lab of Cardiovascular Disease of Zhejiang Province, Hangzhou, Zhejiang, PR China.
Department of Vascular Surgery, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, PR China.
Atherosclerosis. 2019 Oct;289:64-72. doi: 10.1016/j.atherosclerosis.2019.08.016. Epub 2019 Aug 25.
Abdominal aortic aneurysm (AAA) is characterized by infiltration of inflammatory cells, extracellular matrix (ECM) degradation, and dysfunction of vascular smooth muscle cells (VSMCs). Recent studies reported that exosomes mediate intercellular communication and are involved in different diseases. Whether exosomes play a role in AAA is poorly understood. Hence, this study evaluated the function of exosomes in AAA development.
The presence of exosomes in human and calcium phosphate (CaPO)-induced AAA tissues was determined by immunofluorescence staining of CD63 and Alix. GW4869, an inhibitor of exosome biogenesis, was intraperitoneally injected into CaPO-induced AAA tissues to evaluate the effects of exosomal inhibition on AAA development. To explore the underlying mechanisms, the human monocytic cell line THP-1 was differentiated into macrophages, and exosomes were collected from macrophages. VSMCs were treated with macrophage-derived exosomes, and the expression of matrix metalloproteinase-2 (MMP-2) was evaluated. The activation of mitogen-activated protein kinases (MAPKs) pathways was also investigated in vitro and in vivo.
Exosomes were detected in the adventitia of aneurysmal tissues obtained from humans and mice. They were mainly expressed in clusters of macrophages. Intraperitoneal injection of GW4869 for two weeks significantly attenuated the progression of CaPO-induced AAA, preserved elastin integrity and decreased MMP-2 expression. Similarly, administration of GW4869 suppressed the systemic and aneurysmal exosome generation. In vitro, treatment with macrophage-derived exosomes elevated MMP-2 expression in human VSMCs, while pre-treatment with GW4869 abolished these effects. It was also found that JNK and p38 pathways mediated the production of MMP-2 in VSMCs following treatment with macrophage-derived exosomes.
This study suggests that exosomes derived from macrophages are involved in the pathogenesis of AAA. Macrophage-derived exosomes trigger MMP-2 expression in VSMC via JNK and p38 pathways. GW4869 supplementation attenuates CaPO-induced AAA in mice.
腹主动脉瘤(AAA)的特征是炎症细胞浸润、细胞外基质(ECM)降解和血管平滑肌细胞(VSMC)功能障碍。最近的研究表明,外泌体介导细胞间通讯,并参与不同的疾病。外泌体是否在 AAA 中起作用尚不清楚。因此,本研究评估了外泌体在 AAA 发展中的作用。
通过免疫荧光染色 CD63 和 Alix 检测人及磷酸钙(CaPO)诱导的 AAA 组织中外泌体的存在。腹腔内注射外泌体生物发生抑制剂 GW4869 以评估外泌体抑制对 AAA 发展的影响。为了探讨潜在机制,将人单核细胞系 THP-1 分化为巨噬细胞,并从巨噬细胞中收集外泌体。用巨噬细胞衍生的外泌体处理 VSMC,评估基质金属蛋白酶-2(MMP-2)的表达。还在体外和体内研究了丝裂原活化蛋白激酶(MAPK)途径的激活。
在从人和小鼠获得的动脉瘤组织的外膜中检测到外泌体。它们主要在巨噬细胞簇中表达。GW4869 腹腔注射两周可显著减轻 CaPO 诱导的 AAA 的进展,保持弹力蛋白完整性并降低 MMP-2 的表达。同样,GW4869 的给药抑制了全身和动脉瘤外泌体的产生。在体外,用巨噬细胞衍生的外泌体处理可增加人 VSMC 中 MMP-2 的表达,而用 GW4869 预处理则消除了这些作用。还发现 JNK 和 p38 途径介导了巨噬细胞衍生的外泌体处理后 VSMC 中 MMP-2 的产生。
本研究表明,巨噬细胞衍生的外泌体参与了 AAA 的发病机制。巨噬细胞衍生的外泌体通过 JNK 和 p38 途径触发 VSMC 中 MMP-2 的表达。GW4869 补充可减轻小鼠 CaPO 诱导的 AAA。